Bayer HealthCare Pharmaceuticals announced that the investigational drug radium-223 chloride showed positive data in the Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial. The study met its primary endpoint by significantly improving overall survival by 44% (p=0.00185...
ok so i want to order a dog tag ( from nickssimplewins.com) and i was just wondering how long it would take to come to Australia? Also is it really breakable/rusty if something happens? or is it actual steel?
IF u want share your experience with the nick jonas dog tag you have :)
im a big...
Bayer Schering Pharma AG, Germany, announced that data from Phase I and II studies evaluating two of the company's late-stage pipeline cancer treatments AlpharadinTM (radium-223 chloride) and regorafenib (BAY 73-4506) will be presented at the 35th European Society for Medical Oncology (ESMO)...
Bayer today announced that a novel, convenient single-drug treatment approach with oral rivaroxaban met the primary efficacy endpoint of non-inferiority in the EINSTEIN-DVT Phase III clinical trial and showed an overall relative risk reduction compared to the current standard therapy in the...
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus'...
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus'...